Singulex Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Singulex Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6566
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and physicians in identifying the biomarkers of disease. Singulex’s SMC technology offer ultrasensitive lab testing services for facilitating proactive health management. The company also provides immunoassay kits and reagents and immunoassay systems. It offers services such as clinical lab testing, patient lab testing, wellness programs, clinical laboratory consulting and billing and client services. The company’s technology is used for medical practice or clinical diagnostics and scientific research applications. Singulex is headquartered in Alameda, California, the US.

Singulex Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Singulex Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Singulex Raises US$55 Million In Financing Round 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Partnerships 14
Singulex Enters into Licensing agreement with Thermo Fisher Scientific 14
Singulex Enters into Licensing Agreement with Grifols 15
Singulex Enters into Agreement with Qiagen 16
Singulex Forms Joint Venture with Technology Foundation STW 17
Singulex Enters into Development Agreement with CHDI Foundation 18
Singulex Enters Into Co-Development Agreement With Tecan 19
EMD Millipore Enters into Licensing Agreement with Singulex 20
Equity Offering 21
Grifols Invests USD50 Million in Singulex 21
Singulex Withdrawn IPO For Up To US$86 Million 22
Singulex Inc – Key Competitors 23
Singulex Inc – Key Employees 24
Singulex Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Singulex Inc, Medical Equipment, Key Facts 2
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Deals By Market, 2012 to YTD 2018 8
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Singulex Raises US$55 Million In Financing Round 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Singulex Enters into Licensing agreement with Thermo Fisher Scientific 14
Singulex Enters into Licensing Agreement with Grifols 15
Singulex Enters into Agreement with Qiagen 16
Singulex Forms Joint Venture with Technology Foundation STW 17
Singulex Enters into Development Agreement with CHDI Foundation 18
Singulex Enters Into Co-Development Agreement With Tecan 19
EMD Millipore Enters into Licensing Agreement with Singulex 20
Grifols Invests USD50 Million in Singulex 21
Singulex Withdrawn IPO For Up To US$86 Million 22
Singulex Inc, Key Competitors 23
Singulex Inc, Key Employees 24
Singulex Inc, Joint Venture 25

List of Figures
Singulex Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Singulex Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析
    Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ionis Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Ionis Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ionis Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Polyplex (Thailand) Public Company Limited:企業の戦略・SWOT・財務分析
    Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Frontage Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Frontage Laboratories Inc (Frontage), a subsidiary of Hangzhou Tigermed Consulting Co Ltd is a contract research organization that offers early phase drug development and other research services. The organization’s services include clinical research, drug metabolism and pharmacokinetic, CMC …
  • AnaMar AB:製薬・医療:M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …
  • Aclaris Therapeutics Inc (ACRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aclaris Therapeutics Inc (Aclaris Therapeutics) is a dermatologist-led bio-pharmaceutical company which focuses on identifying, developing, and commercializing prescription drug products for unmet needs in aesthetic and medical dermatology as well as immunology. Its lead product, ESKATA, is …
  • The Bank Of East Asia, Limited
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tenaga Nasional Bhd (TENAGA):企業の財務・戦略的SWOT分析
    Tenaga Nasional Bhd (TENAGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Virgin Active Limited:企業の戦略・SWOT・財務分析
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Berkshire Hathaway Energy Co:電力:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • Viscofan, S.A.:企業の戦略・SWOT・財務情報
    Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report Summary Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Fresenius Kidney Care-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius Kidney Care (FMCNA) , formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • NewOcean Energy Holdings Ltd (342):企業の財務・戦略的SWOT分析
    NewOcean Energy Holdings Ltd (342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Hookipa Biotech AG (Hookipa) is a biotechnology company that develops vaccines and next-generation immunotherapeutics for the prevention and treatment of cancer and infectious diseases. The company's lead product candidate include HB101 vaxwave, a vaccine under development for immunization a …
  • China Aerospace Science and Technology Corporation:企業の戦略・SWOT・財務情報
    China Aerospace Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析
    Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Macrogen Inc (038290):企業の財務・戦略的SWOT分析
    Macrogen Inc (038290) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析
    Gemphire Therapeutics Inc (GEMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Biocon Ltd (BIOCON):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocon Ltd (Biocon) is a biopharmaceutical company that focuses on the research and development of therapies for the treatment of chronic conditions like cancer, diabetes and autoimmune. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations; and …
  • Alnylam Pharmaceuticals Inc (ALNY):製薬・医療:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆